Lepu Biopharma Co (HKSE:02157) GF Score : 24/100 (As of Apr. 23, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Lepu Biopharma Co GF Score?

Lepu Biopharma Co has the GF Score of 24, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 3/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 5/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Lepu Biopharma Co might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Lepu Biopharma Co's GF Score

For the Biotechnology subindustry, Lepu Biopharma Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lepu Biopharma Co's GF Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lepu Biopharma Co's GF Score distribution charts can be found below:

* The bar in red indicates where Lepu Biopharma Co's GF Score falls into.

Save Embed

;

Save Embed

;

Lepu Biopharma Co (HKSE:02157) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Lepu Biopharma Co GF Score Related Terms

Thank you for viewing the detailed overview of Lepu Biopharma Co's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Lepu Biopharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lepu Biopharma Co Ltd (HKSE:02157) » Definitions » GF Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 651, Lianheng Road, Minhang District, Shanghai, CHN, 201612

Website

https://www.lepubiopharma.com

Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in the PRC. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain.

Executives

Pu Zhongjie	2201 Interest of corporation controlled by you
Hu Chaohong	2201 Interest of corporation controlled by you
Pu Jue	2201 Interest of corporation controlled by you
Hao Chunmei	2202 Interest of your spouse
Su Rongyu	2101 Beneficial owner
Miracogen Inc.	2201 Interest of corporation controlled by you
Miracogen Limited	2101 Beneficial owner
Cereblue Limited	2201 Interest of corporation controlled by you
Bei Jing Hou De Yi Min Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Hou De Yi Min Xin Xi Ke Ji You Xian Gong Si	2101 Beneficial owner
Le Pu Bei Jing Yi Liao Qi Xie Gu Fen You Xian Gong Si	2101 Beneficial owner
Lv Yuan Shang Hai Ke Ji You Xian Gong Si	2101 Beneficial owner

Lepu Biopharma Co Headlines

No Headlines